Back to search

Article

Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within Interleukin-6 family cytokines

2024-04-26

Abstract excerpt

Although aberrant activation of the KRAS and PI3K pathway alongside TP53 mutations account for frequent aberrations in human gastric cancers, neither the sequence nor the individual contributions of these mutations have been clarified. Here, we establish an allelic series of mice to afford conditional expression in glandular epithelium of Kras G12D ; Pik3ca H1047R or Trp53 R172H and/or ablation of Pten or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c0e5f1db-4413-5aa6-9c5b-6e7469bc623c
DOI
10.1101/2024.04.22.590499
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within Interleukin-6 family cytokinesDOI 10.1101/2024.04.22.590499
Select a neighboring publication to make it the new centre.